Rotavirus Vaccine Market Forecast Highlights Expansion From $11.19 Billion To $16.44 Billion Through 2030
Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Rotavirus Vaccine Market Size, Value And Growth Trends Through 2030
The rotavirus vaccine market has seen rapid expansion in recent years. From $10.14 billion in 2025, it is projected to reach $11.2 billion by 2026, achieving a compound annual growth rate of 10.4%. This historical growth can be explained by a rising incidence of pediatric gastroenteritis, the broadening of national immunization schedules, the strengthening of public health vaccination campaigns, the availability of live attenuated vaccines, and enhanced awareness of rotavirus prevention measures.
The rotavirus vaccine market is projected to experience substantial expansion over the coming years, with an anticipated value of $16.45 billion by 2030, reflecting a compound annual growth rate (CAGR) of 10.1%. This forecasted growth is driven by a rising need for universal pediatric vaccination, the broadening of combination vaccine development, heightened investment in manufacturing capabilities, an intensified emphasis on global immunization coverage, and strengthened partnerships with public health organizations. Key trends shaping this period include the widening reach of pediatric immunization initiatives, a greater adoption of oral vaccine formats, enhanced efforts in cold chain logistics for vaccine storage, the scaling up of public health vaccination campaigns, and improved monitoring of rotavirus infection patterns.
Download A Free Sample Report For Comprehensive Market Insights:
Rotavirus Vaccine Market Expansion Supported By Key Demand Factors
An expected increase in birth rates is projected to drive expansion in the rotavirus vaccine market moving forward. Defined as the number of live births per 1,000 individuals within a population over a given timeframe—most often expressed on an annual basis—birth rates are shaped by greater economic stability and growth, along with supportive measures like parental leave, child benefits, and childcare subsidies. Administering rotavirus vaccines lowers the occurrence of severe rotavirus gastroenteritis in infants, which enhances child health outcomes and cuts healthcare expenses linked to rotavirus infections. For example, in January 2023, the Centers for Disease Control and Prevention—a U.S.-based national public health organization—reported a 1% rise in registered births in the United States, reaching a total of 3,664,292 compared to the prior year. Consequently, the growth of the rotavirus vaccine market will be fueled by rising birth rates.
Rotavirus Vaccine Market Segmentation: How Is The Market Structured Across Key Categories?
The rotavirus vaccine market covered in this report is segmented –
1) By Type: Rotarix, RotaTeq, Rotavac, Rotavin-M1, Lanzhou lamb, Other Types
2) By Application: Adult, Pediatric
3) By End Users: Hospitals, Clinics, Academic Research
Rotavirus Vaccine Market Growth Trends Influencing Competitive Dynamics
Leading players in the rotavirus vaccine sector are increasingly turning to oral-dosing applicators as a strategy to boost vaccine delivery efficiency and enhance patient adherence. These applicators, which are medical tools used for administering liquid medicines or vaccines orally, provide precise dosing and are particularly user-friendly for infants and young children. A notable example occurred in June 2025, when Micron Biomedical, a biotechnology firm based in the U.S., partnered with Emory University, a private U.S. academic institution, to initiate a first-in-human clinical trial for the inactivated rotavirus vaccine CC24. This vaccine is delivered through a dissolvable microarray patch that is thermostable, thereby reducing reliance on cold chains, allows for self-administration, and eliminates sharps waste. While this breakthrough holds promise for expanding vaccine accessibility in low-resource areas, its regulatory approval process is still unproven, and potential challenges in scaling up production could slow its widespread integration into the rotavirus vaccine market.
Rotavirus Vaccine Market Competitive Landscape And Leading Companies
Major companies operating in the rotavirus vaccine market are Merck & Co. Inc., Sanofi S.A., Abbott Laboratories, GlaxoSmithKline plc, Daiichi Sankyo Company Limited, Serum Institute of India Private Limited, Sinovac Biotech Ltd. , SK Chemicals Co Ltd, Bharat Biotech International Limited, Walvax Biotechnology Co. Ltd., Indian Immunologicals Limited, PT Bio Farma, KFF Inc., Panacea Biotec Limited, Sanyou Biopharmaceuticals Co. Ltd., Inovio Pharmaceuticals Inc., Hilleman Laboratories Private Limited, China National Biotec Group Corporation, Vabiotech, Lanzhou Institute of Biological Products Co. Ltd., Nuvonis Pharmaceuticals Inc., Chengdu Institute of Biological Products Co. Ltd
Access The Complete Rotavirus Vaccine Market Report:
Rotavirus Vaccine Market Regional Analysis And Leading Geography
North America was the largest region in the rotavirus vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rotavirus vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
